From: ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL
Sample tissues (23 cases in total) | Sample NO. | Age range (years) | GIS score | P value (vs. non-tumor) | |
---|---|---|---|---|---|
Non-tumor tissue (3 cases) | N1 | 38–65 | 12 |  | |
N2 | 12 | ||||
N3 | 12 | ||||
Glioma tissues | Grade II (3 cases) | G0201 | 26–60 | 4 | 0.0074 |
G0202 | 9 | ||||
G0203 | 6 | ||||
Grade III (9 cases) | G0301 | 32–70 | 2 | 0.0001 | |
G0302 | 2 | ||||
G0303 | 1 | ||||
G0304 | 3 | ||||
G0305 | 8 | ||||
G0306 | 2 | ||||
G0307 | 1 | ||||
G0308 | 0 | ||||
G0309 | 0 | ||||
Grade IV (8 cases) | G0401 | 37–79 | 4 | 0.0001 | |
G0402 | 2 | ||||
G0403 | 0 | ||||
G0404 | 1 | ||||
G0405 | 2 | ||||
G0406 | 4 | ||||
G0407 | 4 | ||||
G0408 | 1 |